20th International Congress » Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)

Date: Monday, June 20, 2016

Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Session Type: Poster Session

Meeting: 20th International Congress

12:30pm-2:00pm: "Atypical" atypical parkinsonism

S.T. Hirschbichler, R. Erro, M. Stamelou, C. Ganos, B. Balint, K.P. Bhatia (London, United Kingdom)

12:30pm-2:00pm: 1-year clinical outcomes in patients with parkinsonism syndrome with/without type 2 diabetes

E. Shalaeva, B. Janabaev, Q. Matmurotov, U. Kasimov, U. Pulatov, A. Bobabekov, M. Bozorboev (Tashkent, Uzbekistan)

12:30pm-2:00pm: A longitudinal observational study of a cohort of patients with PSP/CBD: The JALPAC project

T. Tokuda, T. Ikeuchi, H. Takigawa, I. Aiba, T. Shimohata, M. Morita, O. Onodera, S. Murayama, K. Nakashima (Kyoto, Japan)

12:30pm-2:00pm: A novel phenotype of amyloid precursor protein (APP) mutation presenting with dementia, and symptoms of both progressive supranulcear palsy (PSP) and multisystem atrophy (MSA)

J.E. Staisch, M. Padmanaban, J. Mastrianni, T. Xie (Chicago, IL, USA)

12:30pm-2:00pm: A polysomnography study of REM sleep without atonia and REM sleep behavior disorder in MSA and PD

C. Kaindlstorfer, G. Wenning, S. Bösch, B. Frauscher, F. Krismer, M. Nocker, G. Ransmayr, C. Scherfler, K. Seppi, A. Stefani, W. Poewe, B. Högl (Innsbruck, Austria)

12:30pm-2:00pm: An elderly patient presenting as pure akinesia with gait freezing (PAGF): Idiopathic aqueductal stenosis-associated hydrocephalus

K.Y. Kwon, J.J. Joo, B.J. Ahn, D.K. Yeo (Gumi, Kyeongsangbuk-do, Korea)

12:30pm-2:00pm: Anti-LGI1 encephalitis presenting as a progressive supranuclear palsy-like syndrome

G.A. Da Prat, E.M. Gatto, G.G. Persi, V. Parisi, D. Lisei, L. Rattagan, M. Bres Bullrich, S. Camerlingo, C. Rugilo, M. Titulaer, G. Rojas (Caba, Argentina)

12:30pm-2:00pm: Application and correlates of the PSP quality of life scale

L.A. Higginbotham, V. Johnson, A. Pantelyat (Baltimore, MD, USA)

12:30pm-2:00pm: Apraxia of speech as the initial manifestation of progressive supranuclear palsy

J.J. Bravo, M.J. Gallardo, J.P. Cabello, R.E. Ibañez, J. Vaamonde (Ciudad Real, Spain)

12:30pm-2:00pm: Association between clinical features and pre- and post-synaptic dopaminergic dysfunction in multiple system atrophy: [18F]-FP-CIT PET and [18F]-FDG PET analyses

H.S. Ryu, M. Oh, M.J. Kim, S. You, Y.J. Kim, J. Kim, K. Kim, H. Moon, J. Oh, J.S. Kim, S.J. Chung (Seoul, Korea)

12:30pm-2:00pm: Atypical Parkinsonian disorders: Insights for a differential diagnosis through the analysis of oculomotor profile in MSA, PSP and CBD patients

F. Rosini, G. Lucii, P. Federighi, E. Pretegiani, F. Giannini, R. Rocchi, A. Federico, A. Rufa (Siena, Italy)

12:30pm-2:00pm: Atypical parkinsonism in C9orf72 expansions: A case report and systematic review of 45 cases from the literature

C. Wilke, J.K. Pomper, S. Biskup, C. Puskás, D. Berg, M. Synofzik (Tübingen, Germany)

12:30pm-2:00pm: Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy

C. Vitale, G. Santangelo, R. Allocca, T. Abbate, S. Peluso, G. De Michele, M. Moccia, M. Picillo, D. Tafuri, P. Barone, M. Cavaliere (Naples, Italy)

12:30pm-2:00pm: Bing-Neel syndrome presenting with Parkinsonian features: A case report

P.M. Barbosa, S. D'Sa, K.M. Ardeshna, J. Rees, A.J. Lees, T.T. Warner (London, United Kingdom)

12:30pm-2:00pm: Brain structural abnormalities in multiple system atrophy patients with cognitive impairment

E. Fiorenzato, R. Biundo, L. Weis, K. Seppi, M. Onofrj, P. Cortelli, H. Kaufmann, W. Poewe, F. Krismer, G. Wenning, A. Antonini (Venice-Lido, Italy)

12:30pm-2:00pm: Can deep brain stimulation implantation cause multiple system atrophy? A retrospective review of MSA patients

E.A. Coon, B.T. Klassen, J.E. Ahlskog, P.A. Low, W. Singer (Rochester, MN, USA)

12:30pm-2:00pm: Clinical and instrumental features of multiple system atrophy with laryngeal stridor

M. Todisco, R. Zangaglia, B. Minafra, M. Terzaghi, E. Alfonsi, P. Vitali, C. Pacchetti (Pavia, Italy)

12:30pm-2:00pm: Clinical phenotype (motor and neuropsychological presentation) and neuroimaging in Sardinian patients affected by atypical parkinsonisms, carriers of 20-22 repeats of C9ORF72 hexanucleotide expansion

G. Orofino, A. Cannas, P. Solla, M.M. Mascia, M.R. Murru, G. Borghero (Monserrato, Italy)

12:30pm-2:00pm: Clinical predictors of progressive supranuclear palsy (PSP) pathology in PSP syndrome

I. Aiba, Y. Saito, Y. Yokokawa, M. Kenjo, T. Katayama, R. Hashimoto, S. Sakakibara, A. Inukai, M. Mimuro, Y. Iwasaki, M. Yoshida (Nagoya, Japan)

12:30pm-2:00pm: Clinicopathological characteristics of co-existant Parkinson’s disease and corticobasal degeneration: A case study

K. Andruska, C. Kilbane, E. Plowey, K. Poston (Stanford, CA, USA)

12:30pm-2:00pm: Clusterin CSF levels in differential diagnosis of neurodegenerative disorders

M. Frolova, H. Prikrylova Vranova, E. Henykova, J. Mares, M. Kaiserova, K. Mensikova, M. Vastik, P. Hlustik, J. Zapletalova, M. Strnad, D. Stejskal, P. Kanovsky (Olomouc, Czech Republic)

12:30pm-2:00pm: Cognitive functioning in Parkinson’s disease and Parkinson plus syndrome

S. Mina, V.K. Verma, K.S. Anand (New Delhi, India)

12:30pm-2:00pm: Cognitive impairment in Parkinson’s disease

B. Kurbanov (Tashkent, Uzbekistan)

12:30pm-2:00pm: Cognitive impairment in patients with progressive supranuclear palsy and multiple system atrophy

M. Vecerkova, M. Kaiserova, L. Hvizdosova, S. Kurcova, P. Kanovsky (Olomouc, Czech Republic)

12:30pm-2:00pm: Cognitive profile in the Parkinsonian variant of multiple system atrophy: Findings from a Tunisian cohort

A. Nasri, M. Ben Djebara, I. Kacem, Y. Sidhom, A. Gargouri, R. Gouider (Tunis, Tunisia)

12:30pm-2:00pm: Comparative analysis of freezing of gait in distinct parkinsonism types by diffusion tensor imagining and cognitive profiles

H. Onder, E.S. Topcuoglu, A.C. Has, K.K. Oguz, B. Elibol (Ankara, Turkey)

12:30pm-2:00pm: Comparative gait analysis of patients with vascular parkinsonism and idiopathic Parkinson’s disease

B. Mondal, S. Choudhury, M.U. Kulsum, P. Chatterjee, S. Chatterjee, K. Chatterjee, R. Banerjee, S.S. Jha, S.S. Anand, H. Kumar (Kolkata, India)

12:30pm-2:00pm: Comparison of cognitive and neuropsychological manifestations in patients with progressive supranuclear palsy (Psp) and Parkinson’s disease

M.U. Kulsum, S.S. Anand, S. Chatterjee, P. Chatterjee, B. Mondal, S. Choudhury, K. Chatterjee, R. Banerjee, S.S. Jha, H. Kumar (Kolkata, India)

12:30pm-2:00pm: Composite autonomic symptom scale-31 (COMPASS-31) is useful for evaluation of autonomic dysfunction in patients with parkinsonism

Y. Kim, J.M. Seok, H.J. Kim, J. Youn, B.J. Kim, J.W. Cho (Seoul, Korea)

12:30pm-2:00pm: Could tonic chin electromyogram density be a potential marker for differentiating atypical Parkinsonian syndromes from Parkinson’s disease among alpha-synucleinopathies?

Y. Wang, K.P. Xiong, Y. Shen, P.C. He, C.J. Mao, J. Li, J.Y. Huang, C.F. Liu (Suzhou, People's Republic of China)

12:30pm-2:00pm: Creative thinking and parkinsonism: Preliminary clinical data on the role of frontal area

M. Canesi, M. Rusconi, E. Cereda, F. Moroni, A. Ranghetti, V. Cereda, G. Pezzoli (Milano, Italy)

12:30pm-2:00pm: Dat-SPECT in multiple system atrophy (MSA)

I. Toyoshima, T. Hatakeyama, Y. Takeda, K. Obara, M. Kobsysdhi, C. Wada (Yurihonjo, Japan)

12:30pm-2:00pm: Deep brain stimulation may lead to dramatic worsening of slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature

C. Laurencin, W. Meissner, C. Tranchant, T. Witjas, F. Viallet, P. Damier, T. Danaila, J.L. Houeto, A. Eusebio, S. Thobois (Lyon, France)

12:30pm-2:00pm: Defining the pathology underlying cortico-basal syndrome: A European study

R.C. Lamb, M.C. Darvell, J.D.S. Woodside, J.D. Rohrer, A.J. Lees, H.R. Morris (London, United Kingdom)

12:30pm-2:00pm: Diagnostic value of cardiac 123I-MIBG SPECT and CT co-registration in PD and MSA-P

C. Kaindlstorfer, F. Krismer, A. Fanciulli, S. Eschlböck, M. Nocker, S. Bösch, K. Mair, C. Scherfler, A. Djamshidian-Tehrani, C. Uprimny, E. Donnemiller, I. Virgolini, K. Seppi, W. Poewe, G. Wenning (Innsbruck, Austria)

12:30pm-2:00pm: Disease stage classification of the cerebellar variant of multiple system atrophy based on voxel-based morphometry

T. Taguchi, K. Nanri, Y. Ueta, H. Terashi, H. Aizawa (Tokyo, Japan)

12:30pm-2:00pm: Dorsal simultanagnosia as a cortical sign in the tauopathy spectrum

B. Bergmans, O. Deryck, R. Bruffaerts (Brugge, Belgium)

12:30pm-2:00pm: Drug induced parkinsonism: Role of functional imaging and follow up

A.S. Shetty, H.J. Shah, V.R. Lele, P.M. Wadia (Mumbai, India)

12:30pm-2:00pm: EBM review on the diagnostic work-up of multiple system atrophy

I. Stankovic, A. Antonini, A. Berardelli, C. Colosimo, A. Fanciulli, S. Fox, B. Frauscher, H. Kaufmann, V.S. Kostic, F. Krismer, P. Low, W. Meissner, M.T. Pellecchia, W. Poewe, K. Seppi, S. Tsui, H. Watanabe, G.K. Wenning, On behalf of the MODIMSA EBM Working Group (Belgrade, Serbia)

12:30pm-2:00pm: Generation and characterization of iPSC-derived nigral dopaminergic and pyramidal glutamatergic neurons from patients affected by multiple system atrophy

G. Monzio Compagnoni, E. Frattini, S. Salani, F. Fortunato, N. Bresolin, S. Corti, G.P. Comi, A. Di Fonzo (Milan, Italy)

12:30pm-2:00pm: Glucagon-like peptide 1 analogues for treating multiple system atrophy: A translational study

F. Bassil, M.H. Canron, A. Vital, E. Bezard, Y. Li, N.H. Greig, P.O. Fernagut, W.G. Meissner (Bordeaux, France)

12:30pm-2:00pm: Greater incidence of depressive symptoms in atypical parkinsonism: Importance of early screening

L. Almeida, B. Ahmed, R. Walz, S. De Jesus, A. Patterson, D. Martinez-Ramirez, D. Vaillancourt, D. Bowers, H. Ward, M.S. Okun, M. Armstrong, N. McFarland (Gainesville, FL, USA)

12:30pm-2:00pm: Hand skin temperature and its response to cooling in clinical differentiation of multiple system atrophy and Parkinson’s disease

S. Augustis, T. Fiesel, W.H. Jost (Kaunas, Lithuania)

12:30pm-2:00pm: Health-related quality of life of multisystem atrophy and progressive supranuclear palsy patients

M. Figura, L. Milanowski, B. Kierdaszuk, A. Bartoszek, P. Janik, Z. Jamrozik (Warsaw, Poland)

12:30pm-2:00pm: Heart rate variability and sympathetic skin response are useful in the evaluation of Parkinson’s disease, AMS, and Parkinson plus syndrome, but underutilized in daily clinical practice

R.C. Callejas Rojas, B. Estañol Vidal (Mexico, Mexico)

12:30pm-2:00pm: Imaging-based differential diagnosis between multiple system atrophy and Parkinson’s disease

W. Sako, T. Abe, N. Murakami, Y. Miyazaki, Y. Izumi, M. Harada, R. Kaji (Tokushima, Japan)

12:30pm-2:00pm: Impact of comorbidities and compliance initiatives in management of patients with early Parkinson’s disease

A.V. Shalaeva, N.A. Dadabaeva, R.M. Allanov, M.B. Bozorboev, E. Shalaeva (Tashkent, Uzbekistan)

12:30pm-2:00pm: Incidence of dynamic aphasia in progressive supranuclear palsy

E.I. Giyazitdinova, B.T. Muinjonov, G.S. Rakhimbaeva, Y.A. Musaeva (Taskent, Uzbekistan)

12:30pm-2:00pm: Incidence of dystonia in patients with progressive supranuclear palsy

E.I. Giyazitdinova, B.T. Muinjonov, G.S. Rakhimbaeva, Y.A. Musaeva (Taskent, Uzbekistan)

12:30pm-2:00pm: Initial clinical description of progressive supranuclear palsy in the Luxembourg Parkinson’s study

P. Kolber, G. Hipp, M. Kerschenmeyer, K. Roomp, S.K. Mosch, L. Longhino, A. Schweicher, M. Faltz, V.P. Satagopam, N. Goncharenko, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schneider, R. Krüger (Esch-sur-Alzette, Luxembourg)

12:30pm-2:00pm: Leukocyte perturbations suggest immune dysregulation in progressive supranuclear palsy

M.C. Schiess, J.O. Suescun, A. Actor, A. Gonzales, K.C. Smith (Houston, TX, USA)

12:30pm-2:00pm: Loss of FBXO7 (PARK15) leads to disturbances in proteasomal function and models parkinsonism-like and pyramidal symptoms in mice

S. Vingill, D. Brockelt, N. Schwedhelm-Domeyer, L. Tatenhorst, S. Goebbels, P. Lingor, K.A. Nave, J. Stegmueller (Goettingen, Germany)

12:30pm-2:00pm: Low cerebrospinal fluid 3,4-dihydroxyphenylacetic acid and 3,4-dihydroxyphenylglycol levels are biomarkers of Parkinsonian disorders, including PSP

A. Stefani, C. Holmes, E. Olivola, Y. Sharabi, D. Goldstein (Rome, Italy)

12:30pm-2:00pm: LRRK2, MAPT and HTRA2 mutations in the pedigree of familial neurodegenerative parkinsonism with cognitive deterioration spanning five generations in a genetically isolated population of south-eastern Moravia, Czech Republic

T. Bartonikova, R. Vodicka, K. Mensikova, R. Vrtel, P. Kanovsky, P. Otruba, M. Vastik, L. Mikulicova, S. Kurcova, P. Jugas, J. Ovecka, L. Sachova, F. Dvorsky (Olomouc, Czech Republic)

12:30pm-2:00pm: Magnetic resonance characteristic of Parkinson’s disease based on the presence of cognitive impairment

F.B. Doniyorova (Tashkent, Uzbekistan)

12:30pm-2:00pm: MicroRNA as diagnostic biomarkers in Parkinson’s disease and multiple system atrophy

C.C. Starhof, K. Winge, N. Heegaard, A.M. Hejl (København, Denmark)

12:30pm-2:00pm: Midbrain atrophy differentially progresses between Richardson’s Syndrome, progressive supranuclear palsy-parkinsonism and Parkinson’s disease: Longitudinal MRI study

Y.E. Huh, M. Hwang, J.K. Park, J.W. Cho (Seoul, Korea)

12:30pm-2:00pm: Mild Parkinsonian signs and TIA/stroke

J.L. Adams, N. Dahodwala (Rochester, NY, USA)

12:30pm-2:00pm: Modeling trajectories of brain damage in progressive supranuclear palsy: A longitudinal multimodal MRI study

F. Caso, F. Agosta, M. Lukic-Jecmenica, I. Petrovic, P. Valsasina, P.M. Ferraro, A. Meani, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)

12:30pm-2:00pm: Movement disorders after stroke in the third Moroccan level hospital, Marrakech

A. Chahidi, M. Chraa, N. Kissani (Beni Mellal, Morocco)

12:30pm-2:00pm: Movement disorders in patients with Japanese encephalitis: Experience in a tertiary care hospital in north eastern region of India

A.R. Barua, N.C. Borah, P.S. Deb, A. Hatibaruah (Guwahati, India)

12:30pm-2:00pm: MRI-supported diagnosis of multiple system atrophy: Implications for clinical trials

F. Krismer, G.K. Wenning, S. Bajaj, M. Schocke, C. Scherfler, W. Poewe, K. Seppi (Innsbruck, Austria)

12:30pm-2:00pm: Multimodal voxel-based analysis of the infratentorial brain region in Richardson’s syndrome, progressive supranuclear palsy-parkinsonism, Parkinson variant of multiple system atrophy and Parkinson’s disease

M. Seki, C. Müller, E. Reiter, M. Nocker, M. Schocke, E. Gizewski, C. Kremser, G. Wenning, W. Poewe, K. Seppi, C. Scherfler (Innsbruck, Austria)

12:30pm-2:00pm: Multiple system atrophy with motor fluctuations: A presynaptic disease variant?

Y. Compta, S.C. Cerquera, N. Falgàs, E. Gelpí, V. Puente, A. Cámara, L. Planellas, M.J. Martí, F. Valldeoriola (Barcelona, Spain)

12:30pm-2:00pm: Multiple system atrophy: A comparison between clinical subtypes

L.B. Barcelos, R.A. Saba, S.M.A. Silva, V. Borges, H.B. Ferraz (Sao Paulo, Brazil)

12:30pm-2:00pm: Muscle ceroid-lipofuscine-like deposits in a patient with FTD due to a progranulin mutation

R. Terlizzi, M.L. Valentino, A. Bartoletti-Stella, M. Columbaro, S. Piras, P. Martinelli, P. Parchi, S. Capellari (Bologna, Italy)

12:30pm-2:00pm: Non-motor symptoms in progressive supranuclear palsy

R. Ou, W. Song, Q. Wei, K. Chen, B. Cao, Y. Hou, B. Zhao, H. Shang (Chengdu, People's Republic of China)

12:30pm-2:00pm: Oxysterol and chitotriosidase as biomarkers for atypical Parkinsonian symptoms?

M. Schuberth, G. Nübling, J. Hauer, T. Marquardt, S. Lorenzl (München, Germany)

12:30pm-2:00pm: Pan American multiple system atrophy (PANMSA) consortium database

M. Cesarini, A. Sanguinetti, J. Etcheverry, E. Mosto, I. Litvan, E.M. Gatto (Buenos Aires, Argentina)

12:30pm-2:00pm: Parkinson’s syndrome as possible manifestation of lamina quadrigemina tumor or inflammation

N.M. Pavlyshyna, I.V. Khubetova (Odessa, Ukraine)

12:30pm-2:00pm: Parkinsonism and movement disorders in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

I. Amorín, A. Lescano, A. Panuncio, V. Raggio, R. Buzó (Montevideo, Uruguay)

12:30pm-2:00pm: Parkinsonism in patients with CADASIL

S.K. Song, J.H. Kang (Jeju-si, Korea)

12:30pm-2:00pm: Prevalence and characterisation of vocal fold motion impairment (VFMI) in patients with multiple system atrophy

M. Renaud, D. Robert, A. Lagier, H. Somma, S. Soulayrol, D. Korchia, F. Fluchère, S. Grimaldi, T. Witjas, J.P. Azulay, A. Eusebio (Marseille, France)

12:30pm-2:00pm: Prevalence and incidence of PSP and CBS: A new prospective study in the UK

J.B. Rowe, I.T. Coyle-Gilchrist (Cambridge, United Kingdom)

12:30pm-2:00pm: Progression of microglial activation and neuroinflammatory responses in a transgenic mouse model of multiple system atrophy

V. Refolo, S. Venezia, G.K. Wenning, M. Romero-Ramos, N. Stefanova (Innsbruck, Austria)

12:30pm-2:00pm: Progressive supranuclear palsy as a manifestation of the second stage of CADASIL syndrome

B. Muinjonov, E. Giyazitdinova, G. Rakhimbaeva (Tashkent, Uzbekistan)

12:30pm-2:00pm: PROSPECT: A UK-based longitudinal observational study of PSP, CBD, MSA and atypical parkinsonism syndromes

J. Woodside, R. Lamb, V. Chelban, D. Burn, A. Church, A. Gerhard, M. Hu, N. Leigh, J. Rowe, H. Houlden (London, United Kingdom)

12:30pm-2:00pm: PSP and HIV: Causality or coincidence?

L.A. Crespo Araico, P. Agüero Rabes, E. Viedma Guiard, P. Martinez Ulloa, C. Estévez Fraga, A. Alonso Cánovas, I. Corral Corral, L. Cabañes Martinez, E. Navas Elorza, J.C. Martinez Castrillo, I. Avilés Olmos (Madrid, Spain)

12:30pm-2:00pm: Quantification of striatal dopamine transporters with [18F]PR04.MZ in patients with progressive supranuclear palsy and Parkinson’s disease

P. Chana-Cuevas, C. Juri, V. Kramer, R. Pruzzo, P. Riss, A. Amaral, F. Rösch, H. Amaral (Santiago, Chile)

12:30pm-2:00pm: Quantitative MRI measurement of regional cerebellar involvement in patients with progressive supranuclear palsy

Y. Lee, D.K. Lee, J.M. Lee, S.J. Chung, J.J. Lee, Y.H. Sohn, P.H. Lee (Seoul, Korea)

12:30pm-2:00pm: Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy

F. Bassil, P.O. Fernagut, E. Bezard, Q. Hoang, D. Ringe, G.A. Petsko, W.G. Meissner (Bordeaux, France)

12:30pm-2:00pm: Sleep disorders in progressive supranuclear palsy

B. Muinjonov, E. Giyaziddinova (Tashkent, Uzbekistan)

12:30pm-2:00pm: Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism

F. Krismer, B. Pinter, C. Müller, P. Mahlknecht, M. Nocker, E. Reiter, A. Djamshidian-Tehrani, S.M. Bösch, G.K. Wenning, C. Scherfler, W. Poewe, K. Seppi (Innsbruck, Austria)

12:30pm-2:00pm: Subjective report does not predict objective swallow impairment in atypical Parkinsonian syndromes

L. Shahgholi, S. De Jesus, A. Paterson, W. Deeb, N.R. McFarland, K. Hegland (Gainesville, FL, USA)

12:30pm-2:00pm: Targeting TLR4 for disease modification in multiple system atrophy: Experimental evidence

S. Venezia, V. Refolo, N. Stefanova (Innsbruck, Austria)

12:30pm-2:00pm: Tau dysfunction in the basal ganglia of a mouse model of tauopathy related to PSP

A. Damianich, M. Sartor, S. Espindola, I.R.E. Taravini, O.S. Gershanik, J.E. Ferrario, M. Avale (Buenos Aires, Argentina)

12:30pm-2:00pm: The basal ganglia muscarine receptors impairment in progressive supranuclear palsy

B. Muinjonov, E. Giyaziddinova, G. Rakhimbaeva (Tashkent, Uzbekistan)

12:30pm-2:00pm: The Catalan multiple system atrophy-registry (CMSAR)

F. Antonelli, E. Muñoz, J. Pagonabarraga, J. Hernández-Vara, A. Bayes, O. de Fabregues, F. Valldeoriola, E. Tolosa, Y. Compta, M. Ezquerra, R. Fernandez, M. Calopa, S. Jauma, M. Pujol, V. Puente, A. Cámara, L. Planellas, M.J. Martí (Barcelona, Spain)

12:30pm-2:00pm: The condition of cerebral hemodynamics in the secondary vascular parkinsonism

D. Akramova, A. Umarov, G. Rakhimbaeva, M. Ataniyazov, D. Shosaidova (Tashkent, Uzbekistan)

12:30pm-2:00pm: The importance of Ishihara testing in early diagnosing of Parkinson’s disease

S. Mirdedaev, K. Mirzayeva, D. Baykhonova (Tashkent, Uzbekistan)

12:30pm-2:00pm: The relationship between blood pressure, sex and survival in multiple system atrophy

T. Gurevich, A. Fisher, L. Markin, A. Rozenberg, E. Atanasova Mishkova- Serafimova, D. Klepikov, A. Ezra, J. Knaani, N. Giladi, C. Peretz (Tel Aviv, Israel)

12:30pm-2:00pm: The score changes of clinical symptom assessment scales for multiple system atrophy in 2-3 years

M. Matsushima, I. Yabe, I. Takahashi, K. Sakushima, F. Nakano, M. Hirotani, T. Kano, K. Horiuchi, H. Houzen, H. Sasaki (Sapporo, Japan)

12:30pm-2:00pm: Theta burst repetitive transcranial magnetic stimulation in a case with cortical-basal ganglionic degeneration

A. Demirtas-Tatlidede, Z. Matur, B. Bilgic, H. Hanagasi, M. Emre, H. Gurvit, E. Oge (Istanbul, Turkey)

12:30pm-2:00pm: Three cases of neuronal intranuclear inclusion disease (NIID)

Y. Miyamoto, Y. Morita, K. Furuta, Y. Osaki, H. Arahata, A. Watanabe, N. Fujii, T. Iwaki, H. Furuya (Kochi, Japan)

12:30pm-2:00pm: Transient mild hyperglycemia as diagnostic tool for idiopatic Parkinson’s disease triggered by psychoemotional stress

M.N. Khanova, K.A. Rasulova (Tashkent, Uzbekistan)

12:30pm-2:00pm: Treatment of lipopolysaccharide-induced parkinsonism

I. Niehaus (Rendsburg, Germany)

12:30pm-2:00pm: Triple stimulation technique findings in patients with Parkinson’s disease and multiple system atrophy

H. Wang, Q. Ding, J. Yuan, L. Cui (Beijing, People's Republic of China)

12:30pm-2:00pm: Understanding, predicting, and preventing falls in progressive supranuclear palsy

B.R. Bluett, I. Litvan, S. Cheng, J. Juncos, Y. Bordelon, D.E. Riley, D. Standaert, S.G. Reich, D.A. Hall, B. Kluger, D. Shprecher, C. Marras, J. Jankovic (Las Vegas, NV, USA)

12:30pm-2:00pm: Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia

S. Kurcova, K. Mensikova, L. Tuckova, J. Ehrmann, P. Kanovsky (Olomouc, Czech Republic)

12:30pm-2:00pm: Valproate-induced reversible parkinsonism – A case series

R.M. Simões, N. Inácio, V.B. Silva, A. Arraiolos, P. Alegria, N. Canas, J. Vale (Loures, Portugal)

12:30pm-2:00pm: Zolpidem ameliorates the freezing of gait in a patient with PAGF (pure akinesia with freezing of gait)-the possible neural mechanism

C.H. Tsai, H.C. Huang, J.R. Duann, B.L. Liu, H.C. Lin, M.K. Lu, J.C. Chen (Taichung, Taiwan)

« View all sessions from the 20th International Congress.